Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 61
Filter
1.
Acta Anaesthesiol Scand ; 58(10): 1249-57, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25307710

ABSTRACT

BACKGROUND: Past research has explored patients' expectations about the informed consent process. However, it is currently unknown if the complexity of the surgical procedure influences the type of anesthesia-related risks that patients wish disclosed. This study explored fears of anesthesia-related complications and whether these changed based on severity of surgery classification. METHODS: Patients presenting to our pre-operative evaluation clinic from February 2013 to May 2013 were asked to participate in a survey-based study meant to evaluate their perception of five possible anesthetic risks (peripheral nerve injury, death, nausea and vomiting, heart attack and stroke) when confronted with differing levels of surgical severity. RESULTS: One thousand surveys were administered, and 894 were returned for an overall response rate of 89%. Fear of death was the greatest concern as compared to the other risk factors independent of the severity of surgery. The level of fear for all risk factors, with the exception of stroke and heart attack, were dependent on the severity of surgery. Fear of death decreased as the severity of surgery decreased (major 46%, moderate 38%, minor 25%). For major surgery, the fear of perioperative death differed significantly with age (P < 0.001); specifically, with increasing age came a lessened fear of death. CONCLUSION: Awareness by anesthesia providers of those fears that patients report may allow for a more personalized approach to providing information that may better allay anxiety. Further, these results may better tailor the informed consent process to one that meets particular patient concerns.


Subject(s)
Anesthesia/adverse effects , Anesthesia/psychology , Fear/psychology , Informed Consent/psychology , Surgical Procedures, Operative/adverse effects , Surgical Procedures, Operative/psychology , Adolescent , Adult , Age Factors , Aged , Data Collection , Educational Status , Female , Humans , Informed Consent/statistics & numerical data , Male , Middle Aged , Preoperative Care , Surveys and Questionnaires , Young Adult
2.
J Hepatol ; 54(2): 265-71, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21067839

ABSTRACT

BACKGROUND & AIMS: Transjugular intrahepatic stent-shunt (TIPSS) insertion, in patients with uncontrolled gastro-intestinal bleeding, often results in worsening of the systemic hemodynamics which can be associated with intracranial hypertension but the underlying mechanisms are unclear. This study explored the hypothesis that TIPSS insertion results in acute endotoxemia which is associated with increased nitric oxide production resulting in systemic and cerebral vasodilatation. METHODS: Twelve patients with cirrhosis who were undergoing TIPSS for uncontrolled variceal bleeding were studied prior to and 1-h after TIPSS insertion. Changes in cardiac output (CO) and cerebral blood flow (CBF) were measured. NO production was measured using stable isotopes using l-[guanidino-(15)N(2)] arginine and l-[ureido-(13)C;5,5-(2)H(2)] citrulline infusion. The effect of pre- and post-TIPSS plasma on nitric oxide synthase (NOS) activity on human endothelial cell-line (HUVEC) was measured. RESULTS: TIPSS insertion resulted in a significant increase in CO and CBF. Endotoxin and induced neutrophil oxidative burst increased significantly without any significant changes in cytokines. Whole body NO production increased significantly and this was associated with increased iNOS activity in the HUVEC lines. The change in NO production correlated with the changes in CO and CBF. Brain flux of ammonia increased without significant changes in arterial ammonia. CONCLUSIONS: In conclusion, the insertion of TIPSS results in acute endotoxemia which is associated with increased nitric oxide production possibly through an iNOS dependent mechanism which may have important pathophysiological and therapeutic relevance to understanding the basis of circulatory failure in the critically ill cirrhotic patient.


Subject(s)
Critical Illness , Endotoxemia/etiology , Liver Cirrhosis/complications , Nitric Oxide/biosynthesis , Portasystemic Shunt, Transjugular Intrahepatic/adverse effects , Vasodilation , Acute Disease , Ammonia/metabolism , Arginine/metabolism , Cerebrovascular Circulation , Citrulline/metabolism , Cytokines/blood , Female , Humans , Liver Cirrhosis/physiopathology , Male , Middle Aged , Neutrophils/physiology
3.
J Am Assoc Gynecol Laparosc ; 8(2): 263-6, 2001 May.
Article in English | MEDLINE | ID: mdl-11342735

ABSTRACT

STUDY OBJECTIVE: To survey physicians' opinions concerning the impact of pelvic pain mapping on clinical management and surgical decisions. DESIGN: Opinions of physicians based on clinical experience (Canadian Task Force classification III). SETTING: Evening meetings appended to two national meetings. MEASUREMENTS AND MAIN RESULTS: After viewing videotaped interviews, physical examinations, standard laparoscopy, and pelvic pain mapping at laparoscopy in two patients, practicing gynecologists completed questionnaires recording their opinions about the utility of pelvic pain mapping. A second group of gynecologists viewed only one tape. The first group considered pain mapping to be moderately or extremely useful (patient 1, 57.9%; patient 2, 73.7%). Mapping data either made surgeons change the surgical procedure they would have chosen or further clarified the diagnosis (patient 1, 68.4%; patient 2, 84.2%). Of the second group of 67 surgeons, 73% thought that mapping results would have made them change their surgical approach. CONCLUSION: In appropriate cases, pelvic pain mapping during microlaparoscopy under conscious sedation can provide information that may influence surgical decisions as well as general clinical management.


Subject(s)
Laparoscopy , Pelvic Pain/diagnosis , Adult , Chronic Disease , Conscious Sedation , Female , Humans , Pelvic Pain/etiology
4.
J Hypertens ; 19(2): 269-78, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11212970

ABSTRACT

BACKGROUND: Postmenopausal estrogen replacement, with or without progestins, has been related to lower cardiovascular risks. OBJECTIVE: We investigated whether the actions of estrogen on vascular resistance contribute to this cardioprotective effect. DESIGN AND METHODS: In a 6-month double-blind study, pre- and post-treatment blood pressure, cardiac index, total vascular resistance index and plasma catecholamine responses during baseline and mental stressors were compared in 69 women (including 19 with mild hypertension but no history of heart disease). Women were randomized to receive either conjugated estrogens alone, estrogens plus medroxyprogesterone, or placebo. RESULTS: Both groups on active hormone replacement showed similar decreases in vascular resistance and modest blood pressure reductions, which differed from the unchanged responses of those on placebo (P< 0.05) after 3 and 6 months of treatment. Hypertensive women showed greater reductions in vascular resistance than normotensives (P< 0.05) and their blood pressure reductions tended to be larger. Women receiving hormone replacement showed increased stroke volume and cardiac index at 6 months, particularly among hypertensives and those receiving medroxyprogesterone (P < 0.05). Hormone replacement was also related to decreases in plasma norepinephrine. Finally, in 33 women receiving hormone replacement, significant 5 and 3% decreases in echocardiographic measures of left ventricular mass index and relative wall thickness were evident at 6 months (P < 0.05), while 20 placebo-treated women showed no reliable echocardiographic improvements (P= NS). CONCLUSIONS: These findings suggest that estrogen-mediated reductions in hemodynamic load on the heart may contribute to the reduced risk of cardiovascular events in relatively healthy postmenopausal women who use hormone replacement.


Subject(s)
Estrogen Replacement Therapy , Hemodynamics/drug effects , Hypertension/physiopathology , Hypertrophy, Left Ventricular/prevention & control , Adult , Aged , Double-Blind Method , Echocardiography , Female , Humans , Middle Aged , Norepinephrine/blood , Postmenopause/physiology , Ventricular Function, Left
5.
Crit Rev Eukaryot Gene Expr ; 11(4): 319-34, 2001.
Article in English | MEDLINE | ID: mdl-12067070

ABSTRACT

Angiogenesis, or the formation of new vasculature out of preexisting capillaries, is a sequence of events that is essential in the normal physiological processes of tissue growth and in a broad spectrum of pathologies. The diseases in which angiogenesis plays a key role are divided into diseases that are characterized by hypoxia/ ischemia and diseases that are dependent on neovascularization. The formerpathologies may benefit from therapeutic angiogenesis stimulation. This review concentrates on the different strategies to inhibit angiogenesis in diseases that are characterized by excessive angiogenesis, for example, cancer, arthritis, diabetic retinopathy, and inflammatory diseases. These diseases are dependent on the development of newvasculature, and hence, a large variety of different strategies to inhibit angiogenesis are underwayin laboratories throughout the world. At present, over250 angiogenesis inhibitors are described, and approximately half of them display activity in in vivo models. A large percentage of these molecules are natural, nonnatural, or synthetic so-called small molecules. Others are of protein origin, either endogenous or exogenous by nature. The authors highlight the current knowledge on the development of angiostatic proteins and peptides and their potential in the treatment of disease.


Subject(s)
Angiogenesis Inhibitors/physiology , Angiogenesis Inhibitors/pharmacology , Angiostatins , Animals , Antineoplastic Agents/pharmacology , Autoantigens/metabolism , Cell Adhesion/physiology , Cell Migration Inhibition , Collagen/pharmacology , Collagen Type IV/metabolism , Endostatins , Endothelial Growth Factors/antagonists & inhibitors , Endothelium, Vascular/growth & development , Fibroblast Growth Factors/antagonists & inhibitors , Humans , Integrins/antagonists & inhibitors , Integrins/metabolism , Lymphokines/antagonists & inhibitors , Matrix Metalloproteinase Inhibitors , Oligopeptides/pharmacology , PHEX Phosphate Regulating Neutral Endopeptidase , Peptide Fragments/pharmacology , Plasminogen/pharmacology , Proteins/pharmacology , Thrombospondin 1/metabolism , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
6.
Am J Cardiol ; 86(5): 590-2, A10, 2000 Sep 01.
Article in English | MEDLINE | ID: mdl-11009291

ABSTRACT

With use of a randomized, placebo-controlled trial, 62 healthy, postmenopausal smokers and nonsmokers were tested for resting and stress-induced hemodynamic variables before and after 6 months of treatment with either oral hormone replacement therapy or placebo. Smokers had significantly less reduction in both resting and stress-induced vascular resistance and blood pressure after treatment with oral hormone replacement therapy than nonsmokers.


Subject(s)
Estrogens, Conjugated (USP)/pharmacology , Hemodynamics/drug effects , Hormone Replacement Therapy , Postmenopause/physiology , Smoking/physiopathology , Blood Pressure/drug effects , Double-Blind Method , Female , Humans , Medroxyprogesterone/pharmacology , Vascular Resistance/drug effects
7.
J Neurophysiol ; 84(1): 358-66, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10899210

ABSTRACT

Motor-unit synchronization, which is a measure of the near simultaneous discharge of action potentials by motor units, has the potential to influence spike-triggered average force and the steadiness of a low-force isometric contraction. The purpose of the study was to estimate the contribution of motor-unit synchronization to the larger spike-triggered average forces and the decreased steadiness exhibited by old adults. Eleven young (age 19-30 yr) and 14 old (age 63-81 yr) adults participated in the study. Motor-unit activity was recorded with two fine-wire intramuscular electrodes in the first dorsal interosseus muscle during isometric contractions that caused the index finger to exert an abduction force. In a separate session, steadiness measurements were obtained during constant-force isometric contractions at target forces of 2.5, 5, 7. 5, and 10% of the maximum voluntary contraction (MVC) force. Mean (+/-SD) motor-unit forces measured by spike-triggered averaging were larger in old (15.5 +/- 12.1 mN) compared with young (7.3 +/- 5.7 mN) adults, and the differences were more pronounced between young (8.7 +/- 6.4 mN) and old (19.9 +/- 12.2 mN) men. Furthermore, the old adults had a reduced ability to maintain a steady force during an isometric contraction, particularly at low target forces (2.5 and 5% MVC). Mean (+/-SD) motor-unit synchronization, expressed as the frequency of extra synchronous discharges above chance in the cross-correlogram, was similar in young [0.66 +/- 0.4 impulses/s (imp/s); range, 0.35-1.51 imp/s; 53 pairs) and old adults (0.72 +/- 0.5 imp/s; range, 0.27-1.38 imp/s; 56 pairs). The duration of synchronous peaks in the cross-correlogram was similar for each group (approximately 16 ms). These data suggest that motor-unit synchronization is not responsible for larger spike-triggered average forces in old adults and that motor-unit synchronization does not contribute to the decreased steadiness of low-force isometric contractions observed in old adults.


Subject(s)
Aging/physiology , Motor Neurons/physiology , Muscle, Skeletal/innervation , Muscle, Skeletal/physiology , Action Potentials/physiology , Adult , Aged , Aged, 80 and over , Female , Functional Laterality/physiology , Humans , Isometric Contraction/physiology , Male , Middle Aged
8.
J Am Assoc Gynecol Laparosc ; 7(2): 273-5, 2000 May.
Article in English | MEDLINE | ID: mdl-10806278

ABSTRACT

A 23-year-old gravida 1, para 1 woman experienced chronic pelvic pain and cul-de-sac nodularity starting 1 year after laparoscopic cholecystectomy. Repeat laparoscopy revealed numerous clusters of gallstones that were removed, resulting in resolution of her symptoms. Gallstones should be included in the differential diagnosis of the symptomatic patient with a history of cholecystectomy, and surgical records should be carefully reviewed for spillage of stones. It is feasible to remove gallstones laparoscopically.


Subject(s)
Cholecystectomy, Laparoscopic , Cholelithiasis/complications , Pain/etiology , Adult , Cholelithiasis/surgery , Chronic Disease , Female , Humans , Postoperative Complications , Reoperation
9.
Neurosci Lett ; 282(1-2): 9-12, 2000 Mar 17.
Article in English | MEDLINE | ID: mdl-10713384

ABSTRACT

This study tested the hypothesis that vision would improve pitch-plane stabilization of the head by increasing how well neck muscle torque compensates for torques associated with body motion, in a task where standing human subjects made rapid voluntary pulls. Ten subjects performed abrupt horizontal pulls on a handle to two peak force targets, with the eyes open and closed. We evaluated head angular velocity with respect to space. Inverse dynamics were used to subdivide the torque acting on the head into gravito-interactive and muscle components. A torque compensation ratio was computed from those two components. Head angular velocity was lower and the compensation ratio was higher during pulls made with the eyes open, for both force targets. The data suggest that vision enhances head stability by increasing the effectiveness with which muscle torques oppose gravito-interactive torques during voluntary pulls made while standing.


Subject(s)
Head Movements/physiology , Torque , Visual Perception/physiology , Adult , Biomechanical Phenomena , Humans , Motion , Posture/physiology
10.
Eur Cytokine Netw ; 11(1): 39-46, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10705297

ABSTRACT

Elevated NO production mediated by activation of the enzyme iNOS is thought to play a central role in the development of tissue damage observed during septic shock. IFN-gamma, TNF-alpha and IL-10 have been shown to be involved in the regulation of LPS-induced serum levels of the NO-oxidation products nitrate and nitrite. Therefore, in the present study, we investigated the role of endogenous IFN-gamma, TNF-alpha and IL-10 in the regulation of LPS-induced tissue iNOS expression in the major organs. To this end, mice were pre-treated with anti-IFN-gamma, anti-TNF-alpha, anti-IL-10 monoclonal antibodies, or combinations of these, two hours before intraperitoneal LPS-challenge. Immunohistochemical staining for iNOS and determination of iNOS activity indicated that iNOS expression was mainly upregulated in the small intestine, lung and heart, and that IFN-gamma, TNF-alpha as well as IL-10 are involved in the regulation of iNOS expression and enzyme activity. Whereas blocking either IFN-gamma or TNF-alpha did not affect iNOS expression, iNOS enzymatic activity seems to be inhibited. In contrast, blocking both mediators nearly completely prevents iNOS expression after LPS challenge, suggesting that the presence of either IFN-gamma or TNF-alpha is essential for LPS-induced iNOS expression in these organs. Combined treatment of these monoclonal antibodies revealed that whereas on the one hand IL-10 inhibits LPS-induced iNOS expression, on the other hand IL-10 or an IL-10 inducible factor is also involved in the upregulation of iNOS expression after LPS challenge.


Subject(s)
Antibodies, Monoclonal/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Interferon-gamma/physiology , Interleukin-10/physiology , Lipopolysaccharides/pharmacology , Nitric Oxide Synthase/genetics , Tumor Necrosis Factor-alpha/physiology , Animals , Enzyme Induction , Escherichia coli , Female , Gene Expression Regulation, Enzymologic/immunology , Interferon-gamma/immunology , Interleukin-10/immunology , Intestinal Mucosa/enzymology , Intestine, Small/enzymology , Lung/enzymology , Mice , Myocardium/enzymology , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase Type II , Organ Specificity , Tumor Necrosis Factor-alpha/immunology
12.
Am J Obstet Gynecol ; 181(3): 567-75, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10486465

ABSTRACT

OBJECTIVE: We sought to determine the utility of routinely collected administrative data for risk adjustment for complications of hysterectomy. STUDY DESIGN: Using abstracted discharge data on 107, 648 women undergoing hysterectomy in North Carolina from 1988 through 1994, we constructed logistic regression models for the prediction of medical and surgical complications incorporating coded demographic, diagnostic, and procedural data. RESULTS: The overall complication rate was 16%, with surgical complications (11.8%) more common than medical complications (6.7%). Hysterectomy type, teaching hospital status, patient age >/=65 years, and insurance status of Medicaid or no insurance were significantly associated with both medical and surgical complication risk, as were procedures performed for cancer or pregnancy complications. Models that incorporated coded comorbidity were better predictors of medical complications (C = 0.714) than surgical complications (C = 0.630). CONCLUSION: Although surgical complications of hysterectomy are more common than medical complications, risk adjustment methods that use routinely collected administrative data are better at predicting medical complications. Ambiguities in coding, misclassification, and uncoded factors such as disease severity limit the utility of administrative data for risk adjustment for hysterectomy complications.


Subject(s)
Data Collection/methods , Hysterectomy/adverse effects , Postoperative Complications/epidemiology , Adult , Female , Humans , Logistic Models , Middle Aged , Patient Discharge , Risk Factors
13.
Shock ; 11(2): 115-9, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10030798

ABSTRACT

Enhanced intestinal nitric oxide production observed during sepsis is thought to play a central role in lipopolysaccharide-induced intestinal damage. In contrast intestinal polyamines, both from endogenous and exogenous origin, are essential for the maintenance of mucosal integrity. Polyamines have been shown to inhibit lipopolysaccharide-induced nitric oxide release in vitro and have been claimed to exert additional antiinflammatory actions. In this study, the effect of the polyamine spermine on the release of the proinflammatory mediators nitric oxide and tumor necrosis factor-alpha by a murine macrophage cell line was investigated. Furthermore, we investigated whether oral spermine administration inhibits lipopolysaccharide-induced intestinal inducible nitric oxide synthase and nitrotyrosine expression and modulates the release of inflammatory mediators. Our results show that although spermine inhibited lipopolysaccharide-induced nitric oxide release in a murine macrophage cell line, no effect on tumor necrosis factor-alpha release was observed. In addition, oral spermine administration inhibited intestinal inducible nitric oxide synthase and nitrotyrosine expression suggesting a protective effect of spermine on lipopolysaccharide-induced intestinal damage. In parallel a decrease in serum levels of the proinflammatory mediators nitrate, nitrite, and interferon-gamma and an increase in the antiinflammatory cytokine interleukin-10 was observed, although tumor necrosis factor-alpha levels were unaffected. These results indicate that spermine inhibits lipopolysaccharide-induced nitric oxide release in vitro as well as in vivo. Further, intraluminally derived polyamines modulate the systemic immune response. It is concluded that oral spermine administration might have therapeutic perspectives for several disorders characterized by systemic inflammation and intestinal damage.


Subject(s)
Intestinal Mucosa/metabolism , Macrophages/drug effects , Nitric Oxide/metabolism , Shock, Septic/drug therapy , Spermine/pharmacology , Administration, Oral , Animals , Disease Models, Animal , Escherichia coli , Female , Immunohistochemistry , Inflammation/chemically induced , Inflammation/drug therapy , Inflammation/metabolism , Interferon-gamma/analysis , Interferon-gamma/blood , Interleukin-10/blood , Intestines/drug effects , Intestines/pathology , Lipopolysaccharides , Macrophages/metabolism , Mice , Neutrophils/drug effects , Nitrates/blood , Nitric Oxide Synthase/analysis , Nitric Oxide Synthase/drug effects , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Nitrites/blood , Shock, Septic/chemically induced , Shock, Septic/metabolism , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/drug effects , Tumor Necrosis Factor-alpha/metabolism , Tyrosine/analogs & derivatives , Tyrosine/analysis , Tyrosine/metabolism
14.
J Womens Health Gend Based Med ; 8(5): 637-46, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10839650

ABSTRACT

Using a randomized, placebo-controlled design, this study assessed the effects of estrogen alone (ES) or in combination with cyclic progesterone (EP) on daily ratings of mood and physical symptoms before and after 6 months of daily hormone treatment. Fifty-four postmenopausal women were recruited from the community at large and specifically selected as being asymptomatic at the time of enrollment and without significant psychiatric history. Ratings were obtained every day for 30 days prior to treatment and again every day during the last 30 days of treatment. Results revealed that when compared with pretreatment levels, women randomized to EP (n = 16) exhibited statistically significant increases in daily depression, cramping, and breast tenderness and a marginally significant increase in daily anxiety. However, these increases were mild, not clinically significant, and did not interfere with normal functioning. Women randomized to ES (n = 20) showed no significant change in daily mood measures, although they did experience an increase in breast tenderness with estrogen. A significant placebo (n = 18) effect was observed, as there was a reliable reduction in daily irritability ratings (p < 0.05) with placebo. These findings suggest that for most postmenopausal women, the use of hormones will not be associated with clinically significant changes in mood or physical symptoms, which weighs favorably into the cost-benefit ratio for women considering hormone replacement therapy.


Subject(s)
Affect/drug effects , Estrogen Replacement Therapy , Estrogens/pharmacology , Postmenopause/drug effects , Progesterone/pharmacology , Female , Humans , Middle Aged
15.
Free Radic Biol Med ; 25(8): 953-63, 1998 Nov 15.
Article in English | MEDLINE | ID: mdl-9840741

ABSTRACT

Inflammation is characterized by increased nitric oxide production. Nitrotyrosine has recently been suggested to be useful as a marker for NO-mediated tissue damage. In context of the development of an ELISA for detection of nitrotyrosine in plasma, monoclonal anti-nitrotyrosine antibodies were developed by injecting mice with nitrated keyhole limpet hemocyanin. The specificity of the antibodies was determined by binding to nitrated BSA, lack of binding to unmodified BSA, tyrosine, 3-chlorotyrosine or phenylalanine and inhibition of binding by nitrotyrosine. The antibodies developed are useful for Western blot analysis and immunohistochemical staining. Using these antibodies a nitrotyrosine sandwich ELISA was developed with a lower detection limit of approximately 0.2 nM. The intra- and interassay variance were 2.4% and 11.9%, respectively. Using this newly developed ELISA, 1.27 +/- 1.03 microM nitrotyrosine was detected in plasma samples of celiac disease patients whereas nitrotyrosine was undetectable in control samples. Elevated nitrotyrosine levels were paralleled by an increase in plasma concentrations of NO-oxidation products (NOx), nitrite and nitrate from 15.1 +/- 6.1 microM in controls to 61.0 +/- 28.2 microM in celiac disease patients. Both nitrotyrosine and NOx levels declined when the patients were on a gluten-free diet, suggesting a relation between intestinal inflammation and plasma nitrotyrosine and NOx levels.


Subject(s)
Celiac Disease/blood , Enzyme-Linked Immunosorbent Assay , Tyrosine/analogs & derivatives , Animals , Antibodies, Monoclonal , Antibody Specificity , Blood Proteins/metabolism , Blotting, Western , Hemocyanins/immunology , Humans , Immunohistochemistry , Mice , Nitrates/blood , Nitrates/immunology , Serum Albumin, Bovine/metabolism , Tyrosine/blood
16.
Fertil Steril ; 70(4): 692-7, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9797100

ABSTRACT

OBJECTIVE: To evaluate the safety profile of endometrial ablation performed with a thermal balloon as defined by serosal temperature elevation and depth of injury. DESIGN: Observational study with histopathologic correlation conducted in ex vivo and in vivo phases. SETTING: Academic medical center. PATIENT(S): Twenty patients undergoing total abdominal hysterectomy. INTERVENTION(S): Endometrial ablation with a thermal balloon. MAIN OUTCOME MEASURE(S): Serosal temperature elevation and histologic depth of injury. RESULT(S): Ex vivo phase results revealed serosal temperatures remained within a safe physiologic range (<45 degrees C). Greatest depth of myometrial injury in the premenopausal uteri was 5.8 mm over the anterior lower uterine segment. In postmenopausal uterus. the greatest depth of myometrial injury was 3.8 mm in the anterior midline. In vivo phase results revealed mean (+/- SD) peak serosal temperatures of 36.1 +/- 1.6 degrees C. As with the ex vivo phase. histologic examination revealed deep endometrial and superficial myometrial damage to all areas. The greatest depth of myometrial injury occurred in the midfundus at 3.4 mm. CONCLUSION(S): No patients experienced complications or adverse events secondary to treatment. Results showed that transuterine thermal injury is a highly unlikely scenario. In both phases of this study, histologic examination revealed that temperatures exposed to the endometrial layer were sufficient to cause tissue damage.


Subject(s)
Catheter Ablation/adverse effects , Catheterization/adverse effects , Hyperthermia, Induced , Menorrhagia/therapy , Adult , Body Temperature Regulation/physiology , Case-Control Studies , Endometrium , Feasibility Studies , Female , Humans , Hysterectomy , Middle Aged , Models, Biological
17.
Am J Obstet Gynecol ; 179(1): 47-55, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9704764

ABSTRACT

OBJECTIVE: This study was designed to evaluate the reliability, validity, and responsiveness of a newly developed, health-related quality-of-life measure. STUDY DESIGN: A total of 137 women (122 from a Phase III clinical trial and 15 from a private practice setting) with endometriosis completed the questionnaire several times. RESULTS: Reproducibility and internal-consistency reliability were acceptable with intraclass correlation coefficients ranging from 0.94 to 1.00 and Cronbach's alpha coefficients ranging from 0.84 to 0.97. Construct validity was demonstrated on the basis of correlations between items and scales. Health-related quality of life varied in a consistent manner according to clinician-rated measures of pelvic pain and dysmenorrhea and patient-reported levels of endometriosis pain, but no relationship emerged according to the revised American Fertility Society classification. In general, the questionnaire was moderately to highly responsive to change. CONCLUSION: This is the first comprehensive health-related quality-of-life questionnaire available for use with endometriosis patients that has demonstrated reliability, validity, and responsiveness.


Subject(s)
Endometriosis/drug therapy , Leuprolide/therapeutic use , Quality of Life , Adolescent , Adult , Demography , Endometriosis/psychology , Female , Humans , Pain Measurement/methods , Psychometrics , Reproducibility of Results , Surveys and Questionnaires
18.
Obstet Gynecol ; 92(3): 321-6, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9721763

ABSTRACT

OBJECTIVE: To compare intraoperative and postoperative outcomes between laparoscopically assisted vaginal hysterectomy and abdominal hysterectomy among patients who are not eligible for vaginal hysterectomy. METHODS: Study subjects were randomly assigned to undergo laparoscopically assisted vaginal hysterectomy or standard abdominal hysterectomy. Intraoperative and postoperative management was similar for each group. Surgical characteristics, complications, length of hospital stay, charges, and convalescence were analyzed. RESULTS: Sixty-five women at three institutions underwent laparoscopically assisted vaginal hysterectomy (n = 34) or abdominal hysterectomy (n = 31). Three patients in the laparoscopic group required conversion to abdominal hysterectomy. Mean operating time was significantly longer for laparoscopically assisted vaginal hysterectomy (179.8 versus 146.0 minutes). There were no differences in blood loss or incidence of intraoperative complications. There was a higher incidence of wound complications in the abdominal hysterectomy group, but no significant difference in the frequency of postoperative complications. Laparoscopically assisted vaginal hysterectomy required a significantly shorter mean hospital stay (2.1 days) and convalescence (28.0 days) than abdominal hysterectomy (4.1 days and 38.0 days, respectively). There were no significant differences in mean hospital charges between the study groups (laparoscopic $8161, abdominal $6974). CONCLUSION: Except for operating time, there are no differences between laparoscopically assisted vaginal hysterectomy and abdominal hysterectomy regarding intraoperative characteristics among abdominal hysterectomy candidates. Postoperatively, laparoscopically assisted vaginal hysterectomy requires a shorter hospital stay and convalescence. Hospital charges are similar between the procedures. A larger number of cases will help determine the indications for laparoscopically assisted vaginal hysterectomy.


Subject(s)
Hysterectomy/methods , Laparoscopy , Adult , Female , Humans , Middle Aged
19.
J Am Assoc Gynecol Laparosc ; 5(3): 265-7, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9668148

ABSTRACT

Pelvic pain mapping during laparoscopy performed under conscious sedation can provide useful information about visceral and somatic sources of chronic pelvic pain. Diagnostic superior hypogastric plexus block can be performed under direct laparoscopic visualization and the pelvis then remapped to determine if painful areas are supplied by hypogastric plexuses. Results of mapping may allow more informed selection of patients for presacral neurectomy.


Subject(s)
Laparoscopy , Nerve Block , Pain Measurement/methods , Pelvic Pain/physiopathology , Adult , Chronic Disease , Conscious Sedation , Endometriosis/complications , Endometriosis/physiopathology , Female , Humans , Laparoscopy/methods , Pelvic Pain/diagnosis , Pelvic Pain/etiology
20.
Obstet Gynecol ; 92(1): 98-103, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9649102

ABSTRACT

OBJECTIVE: To compare the clinical efficacy and safety of a thermal uterine balloon system with hysteroscopic rollerball ablation in the treatment of dysfunctional uterine bleeding. METHODS: Two hundred fifty-five premenopausal women were treated in a randomized multicenter study comparing thermal uterine balloon therapy with hysteroscopic rollerball ablation for the treatment of menorrhagia. Preprocedural and postprocedural menstrual diary scores and quality-of-life questionnaires were obtained. Twelve-month follow-up data are presented on 239 women. RESULTS: Twelve-month results indicated that both techniques significantly reduced menstrual blood flow with no clinically significant difference between the two groups as reflected by return to normal bleeding or less (balloon 80.2% and rollerball ablation 84.3%). Multiple quality-of-life questionnaire results were also similar, including percent of patients highly satisfied with their results (balloon 85.6% compared with rollerball 86.7%). A 90% decrease in diary scores was seen in more than 60% of patients in both groups. Procedural time was reduced significantly in the uterine balloon therapy group. Intraoperative complications occurred in 3.2% of the hysteroscopic rollerball patients, whereas no intraoperative complications occurred in the thermal balloon group. CONCLUSION: In the treatment of dysfunctional uterine bleeding, uterine balloon therapy is as efficacious as hysteroscopic rollerball ablation and may be safer.


Subject(s)
Catheter Ablation/instrumentation , Catheterization/instrumentation , Hot Temperature/therapeutic use , Menorrhagia/therapy , Adult , Equipment Design , Female , Follow-Up Studies , Humans , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...